Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

The successful evaluation of drug treatments and their protocols hinges on the effective gathering and sharing of thorough, timely, and high-quality data. To support this need, the Omda Compos suite of solutions is specifically crafted to enhance the management and effortless exchange of medical information across the clinical landscape. This innovative platform guarantees that users and applications involved in clinical trials and registries have easy access to vital data, fostering improved collaboration and effective data usage. At the heart of the Compos platform lies Omda Compos QR, which features a sophisticated database structure, data warehousing functions, user management, and other critical elements that uphold data integrity throughout the entire process, from collection to analysis. Maintaining streamlined user access and efficient logging practices is crucial for any clinical registry or trial. Within Omda Compos QR, user roles are defined to regulate access to designated sites, thereby enhancing security and control over the data management process. By prioritizing these features, the platform not only supports researchers but also improves the overall quality of clinical data handling.

Description

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Omda

Founded

1999

Country

Norway

Website

omda.com/solutions/health-analytics/omda-compos/

Vendor Details

Company Name

Omda

Founded

1999

Country

Norway

Website

omda.com/solutions/medication-management/omda-cytodose/

Product Features

Product Features

Alternatives

Alternatives